Bone Biologics Corp (BBLGW) Share-based Compensation (2014 - 2025)
Bone Biologics (BBLGW) posted quarterly Share-based Compensation of $45674.0 for Q4 2025, down 54.67% year-over-year from $100754.0 in Q4 2024, and down 47.61% quarter-over-quarter from $87180.0 in Q3 2025.
Bone Biologics Corp (BBLGW) Share-based Compensation (2014 - 2025) Analysis & Trends
Bone Biologics (BBLGW) has reported Share-based Compensation for 10 consecutive years, with $45674.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Share-based Compensation fell 54.67% year-over-year to $45674.0; the TTM figure through Dec 2025 stood at $256358.0 (up 35.77% YoY), while the FY2025 annual figure was $256358.0, up 35.77% from the prior year.
- Share-based Compensation eased to $45674.0 in Q4 2025 per BBLGW's latest filing, from $87180.0 in the prior quarter.
- Across five years, Share-based Compensation topped out at $152844.0 in Q1 2022 and bottomed at $16670.0 in Q2 2023.
- Historically, Share-based Compensation has averaged $54025.6 across 4 years, with a median of $48139.5 in 2025.
- Annual changes were most pronounced in 2023 — Share-based Compensation tumbled 70.71% — and 2025, when it surged 385.93%.
- Bone Biologics' Share-based Compensation stood at $62507.0 in 2022, then rose by 13.81% to $71139.0 in 2023, then soared by 41.63% to $100754.0 in 2024, then slumped by 54.67% to $45674.0 in 2025.
- Business Quant data shows BBLGW's Share-based Compensation at $45674.0 in Q4 2025, $87180.0 in Q3 2025, and $72899.0 in Q2 2025.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 45,674.00 |
| Dec 31, 2025 | 45,674.00 |
| Sep 30, 2025 | 87,180.00 |
| Sep 30, 2025 | 87,180.00 |
| Jun 30, 2025 | 72,899.00 |
| Jun 30, 2025 | 72,899.00 |
| Mar 31, 2025 | 50,605.00 |
| Mar 31, 2025 | 50,605.00 |
| Dec 31, 2024 | 100,754.00 |
| Dec 31, 2024 | 100,754.00 |
| Sep 30, 2024 | 17,941.00 |
| Sep 30, 2024 | 17,941.00 |
| Jun 30, 2024 | 17,443.00 |
| Jun 30, 2024 | 17,443.00 |
| Mar 31, 2024 | 52,681.00 |
| Mar 31, 2024 | 52,681.00 |
| Dec 31, 2023 | 71,139.00 |
| Dec 31, 2023 | 71,139.00 |
| Sep 30, 2023 | 20,026.00 |
| Sep 30, 2023 | 20,026.00 |